ꢀ
E. Wolinska / Tetrahedron 69 (2013) 7269e7278
7276
12.68 (s, 1H), 9.23 (s, 1H), 9.02 (d, J¼8.4 Hz, 1H), 8.15 (dd, J¼1.6,
8.0 Hz, 2H), 7.99 (dd, J¼1.6, 8.0 Hz, 1H), 7.61e7.51 (m, 4H), 7.43e7.36
(m, 4H), 7.33e7.28 (m, 1H), 7.10 (dt, J¼0.8, 8.0 Hz, 1H), 5.65 (dd,
J¼8.8, 10.0 Hz, 1H), 4.82 (dd, J¼8.4, 10.0 Hz, 1H), 4.27 (t, J¼8.4 Hz,
28.7, 19.1, 18.9. HRMS (ESI, m/z): Calcd for C19H25N5ONa ([MþNa]þ),
362.1951, found 362.1942.
4.6.11. 5-tert-Butyl-3-{2-[(4R)-4-benzyl-4,5-dihydro-1,3-oxazol-2-
yl]phenyl}amino-1,2,4-triazine (9k). The product was obtained from
3-chloro-5-tert-butyl-1,2,4-triazine (5d) and 2-[(4R)-4-benzyl-4,5-
dihydro-1,3-oxazol-2-yl]aniline (6c) as a yellow solid, yield 60%
(116 mg). Mp 89e90 ꢀC. IR (KBr) nmax: 3029, 2967, 1633, 1608,
1H). 13C NMR (100 MHz, CDCl3)
d: 164.7, 160.5, 155.5, 142.0, 140.8,
139.2, 134.0, 132.6, 132.1, 129.6, 129.2, 128.8, 127.5, 126.4, 121.0,
119.2, 113.0, 73.2, 70.0. Anal. Calcd for C24H19N5O (393.44): C, 73.27;
H, 4.87; N, 17.80; found: C, 73.29; H, 4.90; N, 17.64.
1528 cmꢁ1. [
a]
20 ꢁ12.7 (c 1.0, CH2Cl2). 1H NMR (400 MHz, CDCl3)
d:
D
4.6.7. 3-{2-[(4S)-4-Isopropyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl}
amino-5-phenyl-1,2,4-triazine (9g). The product was obtained from
3-bromo-5-phenyl-1,2,4-triazine (5c) and 2-[(4S)-4-isopropyl-4,5-
dihydro-1,3-oxazol-2-yl]aniline (6c) as a yellow solid, yield 54%
(98 mg). Mp 138e139 ꢀC. IR (KBr) nmax: 2957, 2895, 2872, 1638,
12.53 (s, 1H), 8.89 (dd, J¼0.4, 8.8 Hz, 1H), 7.87 (dd, J¼1.6, 7.2 Hz, 1H),
7.50 (ddd, J¼1.6, 7.2, 8.8 Hz, 1H), 7.31e7.28 (m, 4H), 7.25e7.21 (m,
1H), 7.02 (ddd, J¼1.2, 8.0, 8.4 Hz, 1H), 4.79e4.72 (m, 1H), 4.35 (t,
J¼8.4 Hz, 1H), 4.11 (t, J¼8.4, 1H), 3.29 (dd, J¼5.4, 14.0 Hz, 1H), 2.85
(dd, J¼8.0, 14.0 Hz, 1H), 1.41 (s, 1H). 13C NMR (100 MHz, CDCl3)
d:
1508 cmꢁ1. [
a
]
D
20 þ20.2 (c 1.01, CH2Cl2). 1H NMR (400 MHz, CDCl3)
d:
169.4, 163.8, 160.1, 140.8, 139.9, 137.7, 132.2, 129.4, 129.3, 128.6,
126.6, 120.6, 118.8, 112.9, 70.4, 67.9, 41.7, 36.7, 28.8. Anal. Calcd for
12.87 (s, 1H), 9.23 (s, 1H), 9.01 (d, J¼8.0 Hz, 1H), 8.17 (d, J¼7.2 Hz,
2H), 7.90 (dd, J¼1.6, 7.6 Hz, 1H), 7.58e7.52 (m, 4H), 7.05 (dt, J¼0.8,
8.4 Hz, 1H), 4.45 (dd, J¼8.4, 9.6 Hz, 1H), 4.27e4.21 (m, 1H), 4.10 (t,
J¼8.4, Hz, 1H), 1.88e1.81 (m, 1H), 1.19 (d, J¼6.4 Hz, 3H), 1.05 (d,
C23H25N5O (387.48): C, 71.29; H, 6.50; N, 18.07; found: C, 71.30; H,
6.43; N, 17.99.
J¼6.4 Hz, 3H). 13C NMR (100 MHz, CDCl3)
d
: 163.3, 160.4, 155.4,
4.6.12. N-Phenyl-2-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]ani-
line (9l). The product was obtained from bromobenzene and 2-
[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (6b) as a col-
140.7,139.0,134.0,132.3, 132.1, 129.3,129.1, 127.5, 120.8, 119.0,113.0,
73.0, 69.6, 33.5, 19.0, 18.9. Anal. Calcd for C21H21N5O (359.42): C,
70.17; H, 5.89; N, 19.48; found: C, 70.09; H, 5.88; N, 19.48.
ourless viscous oil, yield 84% (132 mg). IR (KBr) nmax: 3233, 3170,
20
3029, 2923, 2852, 1629, 1592, 1518 cmꢁ1. [
a
]
þ352.3 (c 1.9,
D
4.6.8. 5-tert-Butyl-3-{2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-
yl]phenyl}amino-1,2,4-triazine (9h). The product was obtained from
3-chloro-5-tert-butyl-1,2,4-triazine (5d) and 2-[(4S)-4-tert-butyl-
4,5-dihydro-1,3-oxazol-2-yl]aniline (6a) as a yellow solid, yield 35%
CH2Cl2). 1H NMR (400 MHz, CDCl3)
d: 10.51 (br s, 1H), 7.90 (dd,
J¼1.2, 7.6 Hz, 1H), 7.39e7.25 (m, 11H), 7.07e7.03 (m, 1H), 6.79 (ddd,
J¼1.2, 6.8, 8.0 Hz, 1H), 5.50 (dd, J¼8.4, 10.0 Hz, 1H), 4.74 (dd, J¼8.0,
10.0 Hz, 1H), 4.17 (t, J¼8.4 Hz, 1H). 13C NMR (100 MHz, CDCl3)
d:
(62 mg). Mp 127e128 ꢀC. IR (KBr) nmax: 3234, 3028, 2958, 2901,
165.1,146.1,142.4,141.3,132.3,130.2,129.2,128.7,127.6,126.5,123.0,
20
2867, 1639, 1615, 1548 cmꢁ1. [
a
]
D
ꢁ0.76 (c 1.02, CH2Cl2). 1H NMR
122.1, 116.9, 113.3, 109.9, 73.2, 70.0. HRMS (ESI, m/z): calcd for
(400 MHz, CDCl3)
d
: 12.72 (s, 1H), 8.98 (d, J¼8.8 Hz, 1H), 8.84 (s, 1H),
C
21H19N2O ([MþH]þ), 315.1492, found 315.1490.
7.87 (dd, J¼1.6, 8.0 Hz,1H), 7.50 (ddd, J¼1.6, 7.2, 8.8 Hz,1H), 7.02 (dt,
J¼0.8, 7.6 Hz, 1H), 4.37e4.33 (m, 1H), 4.25e4.17 (m, 2H), 1.38 (s, 1H),
4.6.13. 3-{2-[(4S)-4-Phenyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl}ami-
nobiphenyl (9m). The product was obtained from 3-bromobiphenyl
and 2-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (6b) as
1.02 (s, 1H). 13C NMR (100 MHz, CDCl3)
d: 169.6, 163.3, 159.8, 140.8,
140.1, 132.3, 129.2, 120.5, 119.0, 112.7, 76.2, 67.4, 36.6, 34.0, 28.7,
25.8. Anal. Calcd for C20H27N5O (353.46): C, 67.96; H, 7.70; N, 19.81;
found: C, 67.79; H, 7.61; N, 19.49.
a colourless viscous oil, yield 44% (85 mg). IR (KBr) nmax: 3225, 3057,
20
3028, 2919, 2897, 1629, 1601, 1579 cmꢁ1. [
a]
þ303.1 (c 0.92,
D
CH2Cl2). 1H NMR (400 MHz, CDCl3)
d: 10.58 (br s, 1H), 7.91 (dd,
4.6.9. 5-tert-Butyl-3-{2-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]
phenyl}amino-1,2,4-triazine (9i). The product was obtained from 3-
chloro-5-tert-butyl-1,2,4-triazine (5d) and 2-[(4S)-4-phenyl-4,5-
dihydro-1,3-oxazol-2-yl]aniline (6b) as a yellow solid, yield 49%
J¼1.6, 8.0 Hz, 1H), 7.60e7.58 (m, 2H), 7.49 (t, J¼1.6 Hz, 1H),
7.45e7.24 (m, 13H), 6.83e6.79 (m, 1H), 5.51 (dd, J¼8.4, 10.0 Hz, 1H),
4.75 (dd, J¼8.4, 10.0 Hz, 1H), 4.19 (t, J¼8.0 Hz, 1H). 13C NMR
(100 MHz, CDCl3) d: 163.6, 146.1, 142.4, 142.3, 141.7, 140.9, 132.4,
(92 mg). Mp 160e162 ꢀC. IR (KBr) nmax: 3232, 3095, 3020, 2962,
130.3, 129.6, 128.8, 128.7, 127.6, 127.3, 127.1, 126.5, 121.9, 120.9,
20
2904, 1632, 1616, 1525 cmꢁ1. [
a]
þ238.6 (c 1.0, CH2Cl2). 1H NMR
120.8, 117.1, 113.5, 110.1, 73.2, 70.0. HRMS (ESI, m/z): calcd for
D
(400 MHz, CDCl3)
d
: 12.57 (s, 1H), 8.95 (dd, J¼0.6, 8.4 Hz, 1H), 8.85
C
27H23N2O ([MþH]þ), 391.1805, found 391.1804.
(m, 1H), 7.96 (dd, J¼1.6, 8.0 Hz,1H), 7.53 (ddd, J¼2.0, 7.6, 8.8 Hz, 1H),
7.41e7.34 (m, 4H), 7.31e7.29 (m, 1H), 7.06 (ddd, J¼0.8, 7.6, 8.0 Hz,
1H), 5.63 (dd, J¼8.6, 10.2 Hz, 1H), 4.81 (dd, J¼8.6, 10.2 Hz, 1H), 4.25
4.7. General procedure for the catalytic enantioselective
Henry reaction
(t, J¼8.6 Hz, 1H), 1.39 (s, 9H). 13C NMR (100 MHz, CDCl3)
d: 169.5,
164.6, 160.0, 142.0, 140.9, 140.0, 132.5, 129.6, 128.7, 127.5, 126.3,
120.7, 119.0, 112.8, 73.1, 69.8, 36.7, 28.8. Anal. Calcd for C22H23N5O
(373.45): C, 70.76; H, 6.21; N, 18.75; found: C, 70.54; H, 6.17; N,
18.62.
A mixture of Cu(OAc)2$H2O (5 mg, 0.025 mmol, 5 mol %) and
ligand 9aek (0.025 mmol, 5 mol %) in anhydrous 2-propanol (2 mL)
was stirred at room temperature for 4 h under argon atmosphere to
give a red-brown solution. The aldehyde (0.5 mmol) and the ni-
tromethane (270 mL, 5 mmol) were added and the reaction was
4.6.10. 5-tert-Butyl-3-{2-[(4S)-4-isopropyl-4,5-dihydro-1,3-oxazol-
2-yl]phenyl}amino-1,2,4-triazine (9j). The product was obtained
from 3-chloro-5-tert-butyl-1,2,4-triazine (5d) and 2-[(4S)-4-
conducted at room temperature for 4 days. Then the solvent was
removed under reduced pressure and the product was isolated by
column chromatography. The ee values of the nitroalcohols 16aer
were determined by chiral HPLC analysis. The absolute configura-
tions of the products were assigned by comparing their specific
rotations or the retention times in HPLC with literature data.3e,25
isopropyl-4,5-dihydro-1,3-oxazol-2-yl]aniline (6c) as
a yellow
solid, yield 70% (119 mg). Mp 89e90 ꢀC. IR (KBr) nmax: 3029, 2956,
2899, 2868, 1636, 1617, 1510 cmꢁ1. [
a
]
D
ꢁ76.3 (c 1.01, CH2Cl2). 1H
20
NMR (400 MHz, CDCl3)
d
: 12.68 (s, 1H), 8.95 (d, J¼8.4 Hz, 1H), 8.83
(s, 1H), 7.87 (dd, J¼1.7, 7.8 Hz, 1H), 7.49 (ddd, J¼1.7, 7.4, 8.8 Hz, 1H),
7.01 (dt, J¼0.9, 8.0 Hz,1H), 4.43 (dd, J¼8.1, 9.4 Hz,1H), 4.22e4.15 (m,
1H), 4.06 (t, J¼8.1 Hz, 1H), 1.87e1.76 (m, 1H), 1.16 (d, J¼6.7, 1H), 1.01
4.7.1. (S)-2-Nitro-1-(3-nitrophenyl)ethanol (16a). Compound 16a
was obtained according to the general procedure and purified by
column chromatography (hexanes/ethyl acetate 2.5:1) to give
(d, J¼6.7 Hz, 1H). 13C NMR (100 MHz, CDCl3)
d: 169.6, 163.4, 159.8,
a colourless solid (100 mg, 95% yield). [
a]
þ20.5 (c 1.25, CH2Cl2).
20
D
20
140.8, 140.0, 132.2, 129.3, 120.5, 118.9, 112.8, 72.9, 69.7, 36.2, 33.6,
[Lit.7h
[a
]
þ36.2 (c 1.25, CH2Cl2), 81% ee]. 1H NMR (400 MHz,
D